• Mashup Score: 9

    Ocular adverse events are common to many antineoplastic agents, although often misunderstood. In most cases, they are easily manageable, but sometimes they require instrumental diagnostics and specific treatments. There are currently no international guidelines for the management of these toxicities. In this review we summarized the main ocular adverse events related to the antineoplastic agents…

    Tweet Tweets with this article
    • While we are chatting about ocular toxicity of cancer therapy, dropping this great review #BrownJC #ophtho https://t.co/sbhjOTlFPo

  • Mashup Score: 0

    Breast pathologists have experimented with robotic dynamic microscopy and traditional whole slide imaging for making the primary diagnosis of breast lesions.1,2 These studies have shown encouraging results however the high cost of these setups has prevented their widespread use. Traditional whole slide imaging for telepathology for breast cases has been utilized for rapid breast care service.2…

    Tweet Tweets with this article
    • Accurate pathologic diagnosis possible virtually by combining static imaging and videoconferencing. A silver lining from the pandemic perhaps? @CBCjournal https://t.co/WeXfRVmSoo

  • Mashup Score: 2

    : In the international, randomized, open-label, phase 3 study SOPHIA trial, margetuximab plus chemotherapy showed improved progression-free survival (PFS), and overall survival (OS) compared with trastuzumab plus chemotherapy. This study aimed to investigate whether margetuximab plus chemotherapy is cost-effective compared with trastuzumab plus chemotherapy in pretreated patients with…

    Tweet Tweets with this article
    • Selecting appropriate patients essential to justify added cost of margituzumab over trastuzumab in advanced, pretreated, HER2-positive breast cancer @CBCjournal https://t.co/d2qxuDHVnR